This second in a two-part series describes how the resilience of a global vaccine network shaped clinical supply is challenged up to the last mile: at clinical sites.
- Building Resilient Clinical Supply Chains To Keep Trials On Track
- Randomization And Trial Supply Management (RTSM) Systems: Meet Your Neighbor Again
- Real-World Data Is Reshaping How We Supply Clinical Trials — And It's About Time
- Why Good Data Still Fails: Inconsistency, Visibility, And Decision Risk
- Designing CNS Trial Supply Chains: A Technical Framework
- Primary Healthcare Disruption And Clinical Trial Supply Risk
- Protecting Clinical Trials From Global Supply Disruptions
- From Passive To Predictive: The New Era Of Clinical Cold Chain Management
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
RTSM/IRT In Clinical Trials: The Complete Guide
RTSM/IRT systems are essential to modern clinical trials. This guide explores how to implement and optimize them to boost efficiency, streamline operations, uphold study integrity, and ensure compliance.
-
Development And Manufacture Of A Highly Potent OSD Product
Highly potent drug compounds require advanced containment and robust technical transfer protocols. CDMOs overcome challenges through meticulous testing, specialized tooling, and strong supplier relationships.
-
Gain Confidence In Clinical Trial Outcomes
Delve into the ways that smart packaging integrations within clinical trial strategies can improve adherence to dosing protocols and provide a comprehensive understanding of a patient’s exposure.
-
Outsourcing Your Highly Potent Oncology Drug Product
Precision oncology treatments require specialized manufacturing and packaging, leading companies to outsource production. Assessing a CDMO’s highly potent processing capabilities is critical.
-
Consolidating Clinical Supply Chain Operations With GxP Inventory
A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.
-
How Modern Software Architecture Is Revolutionizing IRT Solutions
Explore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.
-
Optimizing IRT For Clinical Supply Management
Experts speak on supply capabilities within interactive response technology (IRT) – how flexibility is important to functionality and who to involve and which questions to ask in optimizing IRT for clinical supply.
-
Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization
While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.
-
Solutions For Sponsors Utilizing Drafted Guidance For PROs In Oncology
Explore the challenges pharmaceutical companies face in implementing PROs in cancer clinical trials as outlined in the FDA’s draft guidance, as well as strategies to overcome these obstacles.
-
The Patient-Centric Clinical Supply Chain For Cell And Gene Therapies
This article explores how delivering cell and gene therapies to patients requires new levels of agility, flexibility and innovation in the logistical management of supply.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.